EMAIL THIS PAGE TO A FRIEND

Molecular therapy : the journal of the American Society of Gene Therapy

Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.


PMID 24791940

Abstract

The microRNA (miR)-200s and their negative regulator ZEB1 have been extensively studied in the context of the epithelial-mesenchymal transition. Loss of miR-200s has been shown to enhance cancer aggressiveness and metastasis, whereas replacement of miR-200 miRNAs has been shown to inhibit cell growth in several types of tumors, including lung cancer. Here, we reveal a novel function of miR-200c, a member of the miR-200 family, in regulating intracellular reactive oxygen species signaling and explore a potential application for its use in combination with therapies known to increase oxidative stress such as radiation. We found that miR-200c overexpression increased cellular radiosensitivity by direct regulation of the oxidative stress response genes PRDX2, GAPB/Nrf2, and SESN1 in ways that inhibits DNA double-strand breaks repair, increase levels of reactive oxygen species, and upregulate p21. We used a lung cancer xenograft model to further demonstrate the therapeutic potential of systemic delivery of miR-200c to enhance radiosensitivity in lung cancer. Our findings suggest that the antitumor effects of miR-200c result partially from its regulation of the oxidative stress response; they further suggest that miR-200c, in combination with radiation, could represent a therapeutic strategy in the future.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

333662
1H-1,2,3-Triazole, 97%
C2H3N3
SAB2105613
Anti-D4S234E, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2101297
Anti-KRAS antibody produced in rabbit, affinity isolated antibody
HPA049830
Anti-KRAS antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2107115
Anti-KRAS antibody produced in rabbit, affinity isolated antibody
SAB2700181
Anti-NS3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2502090
Anti-Nsg1 (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA035775
Anti-NSG1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4501190
Anti-NSG1 antibody produced in rabbit, affinity isolated antibody
SAB4503030
Anti-TCTP antibody produced in rabbit, affinity isolated antibody
R3400 Monoclonal Anti-c-K-Ras antibody produced in mouse, clone 234-4.2, purified immunoglobulin, buffered aqueous solution
WH0027065M1
Monoclonal Anti-D4S234E antibody produced in mouse, clone 1C3, purified immunoglobulin, buffered aqueous solution
WH0003845M1
Monoclonal Anti-KRAS antibody produced in mouse, clone 3B10-2F2, purified immunoglobulin, buffered aqueous solution
SAB1404011
Monoclonal Anti-KRAS antibody produced in mouse, clone 4F3, purified immunoglobulin, buffered aqueous solution
SAB4100599
Monoclonal Anti-KRAS antibody produced in mouse, clone KRAS-A582, culture supernatant
SAB4100600
Monoclonal Anti-KRAS antibody produced in mouse, clone KRAS-B582, culture supernatant
WH0007178M1
Monoclonal Anti-TPT1 antibody produced in mouse, clone 3C7, purified immunoglobulin, buffered aqueous solution